Skip to main content

What the FDA labels say about taking them together

Nevirapine and warfarin

Nevirapine's FDA label of July 15, 2026 names warfarin in its drug interactions section; the warfarin label PlainMeds reads does not name nevirapine. The nevirapine label: “Potential effect on anticoagulation. Monitoring of anticoagulation levels is recommended.”

Check it at the source: the nevirapine FDA label on DailyMed (effective July 15, 2026, Mylan Pharmaceuticals Inc.); the warfarin FDA label on DailyMed (effective May 29, 2026, Amneal Pharmaceuticals LLC).

What does the nevirapine label say about warfarin?

Nevirapine label, drug interactions

Drug Name: Antithrombotics: Warfarin; Effect on Concentration of Nevirapine or Concomitant Drug: Plasma concentrations may be increased.; Clinical Comment: Potential effect on anticoagulation. Monitoring of anticoagulation levels is recommended.

Source: FDA drug label (Nevirapine), Mylan Pharmaceuticals Inc., effective July 15, 2026 (SPL set c6e93829-7024-48f6-8023-da6ff27dfc0a), via openFDA; the full label on DailyMed

What does the warfarin label say about nevirapine?

Warfarin's label (effective May 29, 2026) does not name nevirapine in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Warfarin Sodium), Amneal Pharmaceuticals LLC, effective May 29, 2026 (SPL set 558b7a0d-5490-4c1b-802e-3ab3f1efe760), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

6Nevirapine generic labelers
19Warfarin generic labelers
NevirapineWarfarin
Labeled forHIVBlood clots (DVT and PE), Atrial fibrillation
Boxed warningYesYes
Pharmacy cost (NADAC)$0.147 per tablet 200 mg tablet$0.093 per tablet 2 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?